Diagnostic validity of p16, E-cadherin, cyclin D1, p53, and HPV E6/E7 mRNA in CIN 3-like squamous cell carcinoma of the cervix

Overview of attention for article published in Frontiers in oncology, January 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 3 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 19,535 followers.

Diagnostic validity of p16, E-cadherin, cyclin D1, p53, and HPV E6/E7 mRNA in CIN 3-like squamous cell carcinoma of the cervix https://t.co/qbd2fSgB3U

12 Feb 2024

Reply Repost Favourite

RT @FrontOncology: New research: Diagnostic validity of p16, E-cadherin, cyclin D1, p53, and HPV E6/E7 mRNA in CIN 3-like squamous cell car…

27 Jan 2024

Reply Repost Favourite

RT @FrontOncology: New research: Diagnostic validity of p16, E-cadherin, cyclin D1, p53, and HPV E6/E7 mRNA in CIN 3-like squamous cell car…

27 Jan 2024

Reply Repost Favourite

New research: Diagnostic validity of p16, E-cadherin, cyclin D1, p53, and HPV E6/E7 mRNA in CIN 3-like squamous cell carcinoma of the cervix: Objective Cervical intraepithelial neoplasia grade 3 (CIN 3)-like SCC is a recently identified… https://t.co/Ou53

27 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.